ArticleClinical and translational gastroenterology2017
Adventures in Developing an App for Covert Hepatic Encephalopathy.
Article in Clinical and translational gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 8 citations in OpenAlex.
- Blood gas levels, cardiovascular strain and cognitive performance during surgical mask and filtering face piece application.Scientific reports · 2022Trial
- Reactive agility-evidence based suggestions for improvement.Frontiers in sports and active living · 2026Article
- A Qualitative Study on Cryptogenic Hepatic Encephalopathy Screening Cognition Among Hepatology Medical Care Personnel.Journal of multidisciplinary healthcare · 2025Article
- Acceptance and use of a smartphone application in cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2020Article
- Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy.Scientific reports · 2019Observational
- Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2019Review
- Interventions to improve physical function and prevent adverse events in cirrhosis.Gastroenterology report · 2018Review
- Recent advances in hepatic encephalopathy.F1000Research · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patient-reported outcomes (PRO) are critical to understand the spectrum of disease in chronic conditions but are often ignored in clinical practice. Cirrhosis, one of the leading causes of morbidity, is associated with severely impaired PROs likely due to covert hepatic encephalopathy (CHE). The clinical relevance and logistic barriers to routine CHE testing led us to develop the "EncephalApp Stroop App", which is now being used to diagnose CHE. The Primer discusses this example which can potentially be applied to other diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.